| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/2004 | US20040180893 enzymatically or synthetically prepared alpha-hydroxyglycinamide inhibit the replication of HIV in human serum |
| 09/16/2004 | US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation |
| 09/16/2004 | US20040180891 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 09/16/2004 | US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/16/2004 | US20040180889 Cancer treatment; such as [4-(2,5-dimethyl-pyrrol-1-yl)-3-methyl-phenoxy]-acetic acid |
| 09/16/2004 | US20040180888 Phenylindoles for the treatment of HIV |
| 09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/16/2004 | US20040180885 Indole derivatives, process for preparation of the same and use thereof |
| 09/16/2004 | US20040180882 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 09/16/2004 | US20040180881 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/16/2004 | US20040180879 Novel method of treating vasomotor symptoms |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine |
| 09/16/2004 | US20040180876 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis |
| 09/16/2004 | US20040180875 Obesity, anorexia, bulemia, depression, anxiety, psychosis, schizophrenia, migraine, addictive behavior, obsessive-compulsive disorder, sexual disorders |
| 09/16/2004 | US20040180873 Thieno{2,3-d}pyrimidines with combined lh and fsh agonistic activity |
| 09/16/2004 | US20040180870 Containing propylene glycol and 2-propanol or ethanol; clear, long shelf life; nonirritating, freezing resistance; low cost ear drops |
| 09/16/2004 | US20040180869 Such as 21-tert.butyl-17-hydroxy-11 beta-(3-methoxyphenyl)-19-nor-17-alpha-pregna-4,9-dien-20-yn-3-one; high binding efficiency, selectivity; reduced side effects |
| 09/16/2004 | US20040180868 Using leukotriene inhibitor, antihistamine and/or corticosteroid; sinus infections |
| 09/16/2004 | US20040180867 Daily administration of 17 beta-estradiol and every other day including norgestimate |
| 09/16/2004 | US20040180866 Minimizes exposure to hazardous airborne particles; simple, accurate metered dispensing |
| 09/16/2004 | US20040180865 Aspirin and vitamin and/or trace element compositions for the amelioration and treatment of vascular disease |
| 09/16/2004 | US20040180863 Novel, nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 09/16/2004 | US20040180862 Combination of farnesyl diphosphate synthase inhibiting bisphosphonate and squalene synthase inhibitor; counteracting adverse gastrointestinal effects |
| 09/16/2004 | US20040180859 Topical application of borated diamide pyrazine derivative |
| 09/16/2004 | US20040180857 dopamine reuptake inhibitors; for treatment of thoratic outlet obstruction syndrome |
| 09/16/2004 | US20040180856 Aqueous solution including partially methylated cyclodextrin |
| 09/16/2004 | US20040180855 Inhibiting Factor XIa using selective, potent small organic compound having guanidine and azetidine functuality |
| 09/16/2004 | US20040180854 Oligosaccharide aldonic acids and their topical use |
| 09/16/2004 | US20040180853 Allantoin-containing skin cream |
| 09/16/2004 | US20040180852 Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus |
| 09/16/2004 | US20040180850 Polysaccharides with Helicobacter pylori receptor activity; preventing bacteria adhesion; stabilizing gastrointestinal mucus layer against ulcer causing agents |
| 09/16/2004 | US20040180849 Methods and compositions for administration of iron for the treatment of restless leg syndrome |
| 09/16/2004 | US20040180843 Treatment of helicobacter with isothocyanates |
| 09/16/2004 | US20040180842 antibiotics and antiprotozoa agents |
| 09/16/2004 | US20040180841 Enhanced cancer selectivity; compounds having at least one hydroxyl group replaced with alternate functionality |
| 09/16/2004 | US20040180840 Blood brain barrier crossing and/or oral drug delivery; central nervous system tumors and cancer; such as etoposide attached to ethylene glycol oligomer or polymer; blood solubility, in vivo hydrolysis |
| 09/16/2004 | US20040180839 D-mannose contraceptives |
| 09/16/2004 | US20040180838 Effective against trypanosoma brucei rhodiense and leishmania donovani |
| 09/16/2004 | US20040180837 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier |
| 09/16/2004 | US20040180834 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 09/16/2004 | US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis |
| 09/16/2004 | US20040180827 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 09/16/2004 | US20040180824 Combination treatment using exendins and thiazolidinediones |
| 09/16/2004 | US20040180822 Pretreating prior to insertion during tissue repair surgery; promoting healing |
| 09/16/2004 | US20040180817 Use of tumor necrosis factor alpha p75 receptor antagonist or endothelin receptor antagonist, converting enzyme inhibitor or neutralizing agent; reducting cerebral perfusion; method of identifying candidates |
| 09/16/2004 | US20040180816 Combination comprising a p-gp inhibitor and an anti-epileptic drug |
| 09/16/2004 | US20040180814 N-acylated prolinol derivatives; deesterification; Gram-positive bacteria |
| 09/16/2004 | US20040180812 Methods of treating and preventing proliferative disease |
| 09/16/2004 | US20040180809 Low molecular weight, hydrophilic Indole fluorescent dyes for assessing renal, hepatic, cardiac and organ functions; simple, safe, accurate, continuous monitoring |
| 09/16/2004 | US20040180429 Spliceosome mediated RNA trans-splicing in stem cells |
| 09/16/2004 | US20040180392 Identifying statins susceptible to glucoronyl oxidation catalyzed by glucuronyltransferase and non-statin pharmeceutical which inhibit glucoronidation via binding peroxisome proliferator activated receptors for treating and preventing coronary heart disease; side effect reduction |
| 09/16/2004 | US20040180353 Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade |
| 09/16/2004 | US20040180351 Interfering RNA molecules |
| 09/16/2004 | US20040180126 Animal feed with low pufa concentration |
| 09/16/2004 | US20040180106 Proteoglycan compositions for treatment of inflammator diseases |
| 09/16/2004 | US20040180105 Use of a Ginkgo biloba extract for preparing a medicament intended to ease the withdrawal of individuals dependent on the consumption of alcohol, amphetamines, tobacco, drugs inducing toxicomania |
| 09/16/2004 | US20040180102 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 09/16/2004 | US20040180099 Method of reducing toxicity of anticancer agents |
| 09/16/2004 | US20040180097 For encapsulating an unstable drug and/or a drug with unpleasant taste, drug entrapped in pores of grains |
| 09/16/2004 | US20040180096 Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same |
| 09/16/2004 | US20040180095 Biodegradable microspheres are administered by stereotactic injection directly into the tumor, into the peritumoral area or at the same time into the tumor and the peritumoral area |
| 09/16/2004 | US20040180092 For therapy of respiratory or inflammatory complaints in mammals |
| 09/16/2004 | US20040180091 Carbonated hydroxyapatite-based microspherical composites for biomedical uses |
| 09/16/2004 | US20040180090 Treatment of macular degeneration |
| 09/16/2004 | US20040180089 Multilayer dosage forms containing NSAIDs and triptans |
| 09/16/2004 | US20040180088 Controlled release core is capable of swelling rapidly to at least about two times its original volume, and maintaining its physical integrity in gastrointestinal fluids for prolonged periods |
| 09/16/2004 | US20040180087 Include a buffering agent to stabilize and maintain the pH below 9, oral dosage |
| 09/16/2004 | US20040180086 Delivers the drug in a controlled release fashion to the upper small intestine |
| 09/16/2004 | US20040180085 Quickly disintegrating solid preparations |
| 09/16/2004 | US20040180084 Composition for the treatment and prevention of cardiovascular disease, stroke, alzheimer's disease and neurological degeneration |
| 09/16/2004 | US20040180083 Can be filled with a solution having a high water activity, for filling which is selected from the group consisting of medicaments, quasi drugs, cosmetics, health foods, foods, beverages, seasonings, perfumes and bath agents; stability, palatability and texture |
| 09/16/2004 | US20040180082 Dispersing triterpenoid in a polyol while heating; adding a base into the dispersion; dissolving phospholipid in ethanol and adding to dispersion; adding water to prepare emulsion; adding an acid to the emulsion to prepare submicron-liposome |
| 09/16/2004 | US20040180081 Compositions and kits for the removal of irritating compounds from bodily surfaces |
| 09/16/2004 | US20040180080 Fentanyl compound-containing edible patch to be applied to oral mucosa |
| 09/16/2004 | US20040180079 Method and composition |
| 09/16/2004 | US20040180077 Unobtrusive, portable edible strip or film that can be administered inconspicuously without the requirement of a liquid to aid in administration |
| 09/16/2004 | US20040180076 Sterol composition, fat compositions containing the same and foods |
| 09/16/2004 | US20040180066 Useful for threapy of pain/inflammation associated with infection caused by herpes virus, especially herpes simplex virus (HSV) and varicella-zoster virus (VZV) |
| 09/16/2004 | US20040180059 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject |
| 09/16/2004 | US20040180055 Anthrax bio-terrorism: therapeutic technology with "zero" time tolerance |
| 09/16/2004 | US20040180053 Binding protein |
| 09/16/2004 | US20040180052 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 09/16/2004 | US20040180036 Salts of codrugs and uses related thereto |
| 09/16/2004 | US20040180035 Administering to the mammal (i) an immunoconjugate comprising an antibody binding site capable of binding the preselected cell-type and a cytokine capable of inducing a said immune response against the preselected cell-type, and (ii) an angiogenesis inhibitor to enhance immune response |
| 09/16/2004 | US20040180034 Anthelmintic resinates and a method for their preparation |
| 09/16/2004 | US20040180031 Skin conditioner |
| 09/16/2004 | US20040180016 Diluent, alkanoic acid and polyethylene glycol monostearate |
| 09/16/2004 | US20040180015 Also containing an alpha hydroxyl acid or phosphoric acid |
| 09/16/2004 | US20040180013 Cool and dry antiperspirant stick |
| 09/16/2004 | US20040180009 Administering a wound healing agent containing selegiline and/or desmethylselegiline to a subject suffering from photodamaged skin, injury or wound, for a duration sufficient to promote epithelization of such wound |
| 09/16/2004 | US20040180006 Methods and compositions for blocking the calcium cascade |
| 09/16/2004 | US20040180001 antitumor |
| 09/16/2004 | DE3717389B4 Neue naphthylaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in der Human- und Veterinärmedizin und in der Kosmetik New naphthylaromatische compounds, processes for their preparation and their use in human and veterinary medicine and cosmetics |
| 09/16/2004 | DE20320528U1 Neue Kristallformen von Ondansetron und Arzneimittel, welche die neuen Formen enthalten New crystal forms of ondansetron and pharmaceutical compositions containing the new forms |
| 09/16/2004 | DE20220964U1 Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis |
| 09/16/2004 | DE19806354B4 Verwendung von α-Liponsäure oder deren physiologisch verträgliche Salze zur Behandlung von LDL-Hypercholesterinämie Use of α-lipoic acid or its physiologically acceptable salts for the treatment of hypercholesterolemia LDL |
| 09/16/2004 | DE19804376B4 Lipidmischungen sowie deren Verwendung Lipid mixtures and their use |
| 09/16/2004 | DE10310396A1 Treating Parkinson's disease using nefazodone optionally together with trazodone and/or cetirizine, for reducing dopamine requirement and alleviating symptoms |
| 09/16/2004 | DE10310106A1 Substituierte Pyridot [1,2-a]pyrimidin-Verbindungen Substituted Pyridot [1,2-a] pyrimidine compounds |